07:00 , Mar 12, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cardiovascular disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Thrombosis Protein tyrosine phosphatase, receptor type, J (PTPRTJ; CD148); glycoprotein VI (platelet) (GP6; GPVI) A study in mice suggests that...
08:00 , Feb 10, 2003 |  BC Week In Review  |  Company News

Myriad Genetics, Abbott deal

MYGN received a $1 million milestone from ABT triggered by the discovery of DEP1 , a gene that correlated with depression in a study of 400 Utah families with a history of the disease. DEP1...